Meridian Wealth Advisors’s Allergan plc AGN Stock Holding History

Meridian Wealth Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-500	Closed	-$67K	–	442
2018 Q4	$67K	Buy	+500	New	+$82K	0.05%	215

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meridian Wealth Advisors's AGN Position: Q1 2019 in Review

Meridian Wealth Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 500 shares — an estimated $67K sold.

Meridian Wealth Advisors first reported a position in AGN in Q4 2018 and held it in 1 quarter. The position peaked at $67K in Q4 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Meridian Wealth Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
Meridian Wealth Advisors sold 500 Allergan plc shares in Q1 2019, an estimated $67K.
Meridian Wealth Advisors first reported a position in Allergan plc in Q4 2018 and held it in 1 quarter.
Meridian Wealth Advisors's Allergan plc position peaked at $67K in Q4 2018.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Meridian Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.